Literature DB >> 17711390

Sepsis: redox mechanisms and therapeutic opportunities.

Shyam Biswal, Daniel G Remick.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17711390      PMCID: PMC2364730          DOI: 10.1089/ars.2007.1808

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


× No keyword cloud information.
  23 in total

1.  Polymorphonuclear leukocyte dysfunction syndrome in patients with increasing sepsis severity.

Authors:  Ines Kaufmann; Alwin Hoelzl; Florian Schliephake; Theresia Hummel; Alexander Chouker; Klaus Peter; Manfred Thiel
Journal:  Shock       Date:  2006-09       Impact factor: 3.454

2.  Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-Imidazolide.

Authors:  Rajesh K Thimmulappa; Catherine Scollick; Kassim Traore; Melinda Yates; Michael A Trush; Karen T Liby; Michael B Sporn; Masayuki Yamamoto; Thomas W Kensler; Shyam Biswal
Journal:  Biochem Biophys Res Commun       Date:  2006-10-30       Impact factor: 3.575

Review 3.  Role of oxidants in lung injury during sepsis.

Authors:  Ren-Feng Guo; Peter A Ward
Journal:  Antioxid Redox Signal       Date:  2007-11       Impact factor: 8.401

4.  Stilbazulenyl nitrone decreases oxidative stress and reduces lung injury after hemorrhagic shock/resuscitation and LPS.

Authors:  P S Tawadros; K A Powers; I Yang; D A Becker; M D Ginsberg; K Szaszi; A Kapus; O D Rotstein
Journal:  Antioxid Redox Signal       Date:  2007-11       Impact factor: 8.401

Review 5.  Carbon monoxide in sepsis.

Authors:  Alexander Hoetzel; Tamas Dolinay; Rene Schmidt; Augustine M K Choi; Stefan W Ryter
Journal:  Antioxid Redox Signal       Date:  2007-11       Impact factor: 8.401

Review 6.  Redox imbalance and ventilator-induced lung injury.

Authors:  Sekhar P Reddy; Paul M Hassoun; Roy Brower
Journal:  Antioxid Redox Signal       Date:  2007-11       Impact factor: 8.401

7.  Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils.

Authors:  Rajesh K Thimmulappa; Ralph J Fuchs; Deepti Malhotra; Catherine Scollick; Kassim Traore; Jay H Bream; Michael A Trush; Karen T Liby; Michael B Sporn; Thomas W Kensler; Shyam Biswal
Journal:  Antioxid Redox Signal       Date:  2007-11       Impact factor: 8.401

8.  Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003.

Authors:  Viktor Y Dombrovskiy; Andrew A Martin; Jagadeeshan Sunderram; Harold L Paz
Journal:  Crit Care Med       Date:  2007-05       Impact factor: 7.598

9.  Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced trafficking of TLRs to lipid rafts.

Authors:  Kiichi Nakahira; Hong Pyo Kim; Xue Hui Geng; Atsunori Nakao; Xue Wang; Noriko Murase; Peter F Drain; Xiaomei Wang; Madhu Sasidhar; Elizabeth G Nabel; Toru Takahashi; Nicholas W Lukacs; Stefan W Ryter; Kiyoshi Morita; Augustine M K Choi
Journal:  J Exp Med       Date:  2006-09-25       Impact factor: 14.307

10.  Oxidative stress generated by hemorrhagic shock recruits Toll-like receptor 4 to the plasma membrane in macrophages.

Authors:  Kinga A Powers; Katalin Szászi; Rachel G Khadaroo; Patrick S Tawadros; John C Marshall; András Kapus; Ori D Rotstein
Journal:  J Exp Med       Date:  2006-07-17       Impact factor: 14.307

View more
  19 in total

Review 1.  A historical perspective on sepsis.

Authors:  Peter A Ward; Markus Bosmann
Journal:  Am J Pathol       Date:  2012-05-26       Impact factor: 4.307

2.  The reliability of clinical dynamic monitoring of redox status using a new redox potential (ORP) determination method.

Authors:  Lizhu Zhi; Juan Liang; Xinlei Hu; Jun Xu; Chaoheng Yu; Huawei Shao; Xuanliang Pan; Chunmao Han
Journal:  Redox Rep       Date:  2013-03-28       Impact factor: 4.412

3.  A pilot study assessing the prognostic value of CK18 and nDNA biomarkers in severe sepsis patients.

Authors:  David J Moore; Alastair Greystoke; Fouziah Butt; Jens Wurthner; Jim Growcott; Andrew Hughes; Caroline Dive
Journal:  Clin Drug Investig       Date:  2012-03-01       Impact factor: 2.859

4.  Effect of induced mild hypothermia on two pro-inflammatory cytokines and oxidative parameters during experimental acute sepsis.

Authors:  Karelle Léon; Christine Moisan; Aline Amérand; Gwladys Poupon; Erwan L'Her
Journal:  Redox Rep       Date:  2013       Impact factor: 4.412

5.  Enhancing Nrf2 pathway by disruption of Keap1 in myeloid leukocytes protects against sepsis.

Authors:  Xiaoni Kong; Rajesh Thimmulappa; Florin Craciun; Christopher Harvey; Anju Singh; Ponvijay Kombairaju; Sekhar P Reddy; Daniel Remick; Shyam Biswal
Journal:  Am J Respir Crit Care Med       Date:  2011-07-28       Impact factor: 21.405

6.  Combined early fluid resuscitation and hydrogen inhalation attenuates lung and intestine injury.

Authors:  Wei Liu; Li-Ping Shan; Xue-Song Dong; Xiao-Wei Liu; Tao Ma; Zhi Liu
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

7.  Allogeneic human umbilical cord-derived mesenchymal stem cells reduce lipopolysaccharide-induced inflammation and acute lung injury.

Authors:  Shiao-Ya Hong; Sen-Wen Teng; Willie Lin; Cheng-Yi Wang; Hen-I Lin
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

8.  Oxidative Stress in Critically Ill Children with Sepsis.

Authors:  Derek S Wheeler
Journal:  Open Inflamm J       Date:  2011-10-07

9.  The anti-oxidative, anti-inflammatory, and protective effect of S100A8 in endotoxemic mice.

Authors:  Ying Sun; Yu Lu; Christopher G Engeland; Sara C Gordon; Herve Y Sroussi
Journal:  Mol Immunol       Date:  2012-11-03       Impact factor: 4.407

10.  Resveratrol Downregulates Biomarkers of Sepsis Via Inhibition of Proteasome's Proteases.

Authors:  Neerupma Silswal; Nidhi S Reddy; Asaf A Qureshi; Nilofer Qureshi
Journal:  Shock       Date:  2018-11       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.